Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lorlatinib - PF-06463922

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03127618
Expanded Access Status : Available
First Posted : April 25, 2017
Last Update Posted : September 30, 2019
Sponsor:
Information provided by (Responsible Party):
Pfizer

Brief Summary:

Information relating to requesting compassionate access for this investigational drug can be found at the following link:

http://www.pfizer.com/research/compassionate_use


Intervention/treatment
Drug: Lorlatinib

Layout table for study information
Study Type : Expanded Access
Expanded Access Type : Individual Patients
  See clinical trials of the intervention/treatment in this expanded access record.

Resource links provided by the National Library of Medicine




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Criteria

Inclusion Criteria:

  • Adult, Senior

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03127618


Contacts
Layout table for location contacts
Contact: Pfizer CAReS 1-800-718-1021 PfizerCAReS@pfizer.com

Sponsors and Collaborators
Pfizer

Layout table for additonal information
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT03127618     History of Changes
Other Study ID Numbers: B746
First Posted: April 25, 2017    Key Record Dates
Last Update Posted: September 30, 2019
Last Verified: September 2019